|
E.V. Biryukova
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
|
№12 / 2023
|
|
S.V. Podachina, E.V. Biryukova, I.V. Solovievа
Combination therapy for type 2 diabetes maintains its position. Clinical case
|
№3 / 2023
|
|
A.E. Bagriy, O.A. Prikolota, A.V. Prikolota, E.S. Mikhailichenko, I.A. Golodnikov, O.N. Bagriy, K.A. Kotova
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
|
№11-12 / 2022
|
|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
|
N.A. Demidov (1), O.A. Mishra (2), M.B. Antsiferov (3)
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
|
№4 / 2019
|
|
M.B. Antsiferov (1), B.B. Kvasnikov (2)
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
|
№4 / 2019
|
|
M.M. Tanashyan (1), M.Yu. Maksimova (1), K.V. Antonova (1), A.A. Raskurazhev (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
Poststroke recovery in patients with type 2 diabetes mellitus
|
№3 / 2019
|
|
M.B. Antsiferov
THE USE OF INSULIN GLARGINE 300 IU/ML (TOUJEO SOLOSTAR®) IN REAL CLINICAL PRACTICE
|
№16 / 2017
|
|
A.S. Ametov (1), N.A. Chernikova (1), T.Yu. Demidova (1), P.K. Nazhmutdinova (2)
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2016
|
|
N.V. Zaitseva, M.Sh. Shamkhalova
COMBINATION THERAPY WITH GLIMEPIRIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. THE RESULTS OF OBSERVATIONAL STUDIES
|
№16 / 2014
|
|
M.Antsiferov С. 1621
Use Of Long-acting Insulin Analogues In Type 2 Diabetes Mellitus Treatment (according To The Data Of International And Russian Registries)
|
№3 / 2010
|
Русский
